Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound are expected to transition to the ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Musk, the CEO of Tesla and Space X, said that he takes Mounjaro, a drug that treats type-2 diabetes by lowering a person's ...

In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 501.82% and ...

Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound ...

Taxi jumps curb, slams into Christmas Day crowd outside Manhattan Macy’s on W. 34th St. A taxi cab jumped the curb and slammed into six pedestrians walking near Macy's on W. 34th St. and Sixth ...